All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


Relative Articles

Outcomes of Severely Malnourished Children Aged 6 - 59 Months on Outpatient Management Program in Kitui County Hospital, Kenya

New factors of cardiometabolic risk in severely obese children: influence of pubertal status

N-3 Long-Chain Polyunsaturated Fatty Acid Supplementation Significantly Reduces Liver Oxidative Stress in High Fat Induced Steatosis

DUSP1 Gene Polymorphisms Are Associated with Obesity-Related Metabolic Complications among Severely Obese Patients and Impact on Gene Methylation and Expression

Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau

Severely Obese Adolescents and Adults Exhibit a Different Association of Circulating Levels of Adipokines and Leukocyte Expression of the Related Receptors with Insulin Resistance

Pyruvate Administration Reduces Recurrent/Moderate Hypoglycemia-Induced Cortical Neuron Death in Diabetic Rats

Interactive “Video Doctor” Counseling Reduces Drug and Sexual Risk Behaviors among HIV-Positive Patients in Diverse Outpatient Settings

New factors of cardiometabolic risk in severely obese children: influence of pubertal status Nuevos factores de riesgo cardiometabólico en ni os con obesidad severa: influencia del estado puberal

IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation


Moderate Weight Reduction in an Outpatient Obesity Intervention Program Significantly Reduces Insulin Resistance and Risk Factors for Cardiovascular Disease in Severely Obese Adolescents

DOI: 10.1155/2011/541021

Full-Text   Cite this paper   Add to My Lib


Background. Metabolic risk factors like insulin resistance and dyslipidemia are frequently observed in severly obese children. We investigated the hypothesis that moderate weight reduction by a low-threshold intervention is already able to reduce insulin resistance and cardiovascular risk factors in severely obese children. Methods. A group of 58 severely obese children and adolescents between 8 and 17 years participating in a six-month-long outpatient program was studied before and after treatment. The program included behavioral treatment, dietary education and specific physical training. Metabolic parameters were measured in the fasting state, insulin resistance was evaluated in an oral glucose tolerance test. Results. Mean standard deviation score of the body mass index (SDS-BMI) in the study group dropped significantly from +2.5 ± 0.5 to 2.3 ± 0.6 ( ) after participation in the program. A significant decrease was observed in HOMA (6.3 ± 4.2 versus 4.9 ± 2.4, , and in peak insulin levels (232.7 ± 132.4 versus 179.2 ± 73.3?μU/mL, ). Significant reductions were also observed in mean levels of hemoglobin A1c, total cholesterol and LDL cholesterol. Conclusions. These data demonstrate that already moderate weight reduction is able to decrease insulin resistance and dyslipidemia in severely obese children and adolescents. 1. Introduction During the last decade a steady rise in the prevalence of obesity in children and adolescents has been observed worldwide [1, 2] and in several age-groups the extent of obesity was also on the increase. Concurrently certain diseases, characteristically occurring in middle-age adults in association with enhanced body fat mass (e.g., metabolic syndrome and type 2 diabetes), have emerged in children and adolescents with severe obesity, suggesting a coherence between both trends [3, 4]. Likewise, further investigations have shown that obese children and adolescents have a high risk between 30 and 80% for the persistence of overweight into adulthood, and that morbidity and mortality are higher in those obese adults who became overweight during childhood compared to those whose weight-gain evolved later in life [5]. On the other hand epidemiological studies showed that the majority of severely obese adults became overweight when they were still children. A tremendous increase in obesity-related morbidity and furthermore an immense rise in the medical costs associated with it, are to be expected, if this trend continues [6]. For instance, at present type 2 diabetes mellitus is already predominant in some pediatric diabetes


[1]  T. Reinher and M. Wabisch, “Childhood obesity,” Current Opinion in Lipidology, vol. 22, pp. 21–25, 2011.
[2]  C. B. Ebbeling, D. B. Pawlak, and D. S. Ludwig, “Childhood obesity: public-health crisis, common sense cure,” The Lancet, vol. 360, no. 9331, pp. 473–482, 2002.
[3]  R. Kohen-Avramoglu, A. Theriault, and K. Adeli, “Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia,” Clinical Biochemistry, vol. 36, no. 6, pp. 413–420, 2003.
[4]  R. Weiss, J. Dziura, T. S. Burgert et al., “Obesity and the metabolic syndrome in children and adolescents,” The New England Journal of Medicine, vol. 350, no. 23, pp. 2362–2374, 2004.
[5]  C. Maffeis and L. Tatò, “Long-term effects of childhood obesity on morbidity and mortality,” Hormone Research, vol. 55, no. 1, pp. 42–45, 2001.
[6]  G. Wang and W. H. Dietz, “Economic burden of obesity in youths aged 6 to 17 years: 1979–1999,” Pediatrics, vol. 109, no. 5, pp. E81–81, 2002.
[7]  A. H. Mokdad, B. A. Bowman, E. S. Ford, F. Vinicor, J. S. Marks, and J. P. Koplan, “The continuing epidemics of obesity and diabetes in the United States,” Journal of the American Medical Association, vol. 286, no. 10, pp. 1195–1200, 2001.
[8]  S. Wiegand, U. Maikowski, O. Blankenstein, H. Biebermann, P. Tarnow, and A. Grüters, “Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity—a problem that is no longer restricted to minority groups,” European Journal of Endocrinology, vol. 151, no. 2, pp. 199–206, 2004.
[9]  C. Invitti, G. Guzzaloni, L. Gilardini, F. Morabito, and G. Viberti, “Prevalence and concomitants glucose intolerance in European obese children and adolescents,” Diabetes Care, vol. 26, no. 1, pp. 118–124, 2003.
[10]  R. Sinha, G. Fisch, B. Teague et al., “Prevalence of impaired glucose tolerance among children and adolescents with marked obesity,” The New England Journal of Medicine, vol. 346, no. 11, pp. 802–810, 2002.
[11]  R. C. Whitaker and W. H. Dietz, “Role of the prenatal environment in the development of obesity,” Journal of Pediatrics, vol. 132, no. 5, pp. 768–776, 1998.
[12]  N. McLean, S. Griffin, K. Toney, and W. Hardeman, “Family involvement in weight control, weight maintenance and weight-loss interventions: a systematic review of randomised trials,” International Journal of Obesity, vol. 27, no. 9, pp. 987–1005, 2003.
[13]  H. L. Oude, L. Baur, H. Jansen et al., “Interventions for treating obesity in children,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD001872, 2009.
[14]  T. Reinehr and W. Andler, “Changes in the atherogenic risk factor profile according to degree of weight loss,” Archives of Disease in Childhood, vol. 89, no. 5, pp. 419–422, 2004.
[15]  K. Kromeyer-Hauschild, K. Zellner, U. Jaeger, and H. Hoyer, “Prevalence of overweight and obesity among school children in Jena (Germany),” International Journal of Obesity, vol. 23, no. 11, pp. 1143–1150, 1999.
[16]  T. J. Cole, “The LMS method for constructing normalized growth standards,” European Journal of Clinical Nutrition, vol. 44, no. 1, pp. 45–60, 1990.
[17]  J. Giammattei, G. Blix, H. H. Marshak, A. O. Wollitzer, and D. J. Pettitt, “Television watching and soft drink consumption: associations with obesity in 11- to 13-year-old schoolchildren,” Archives of Pediatrics and Adolescent Medicine, vol. 157, no. 9, pp. 882–886, 2003.
[18]  J. Westenhoefer, B. Von Falck, A. Stellfeldt, and S. Fintelmann, “Behavioural correlates of successful weight reduction over 3 y. Results from the Lean Habits Study,” International Journal of Obesity, vol. 28, no. 2, pp. 334–335, 2004.
[19]  P. Warschburger, C. Fromme, F. Petermann, N. Wojtalla, and J. Oepen, “Conceptualisation and evaluation of a cognitive-behavioural training programme for children and adolescents with obesity,” International Journal of Obesity, vol. 25, supplement 1, pp. S93–S95, 2001.
[20]  D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985.
[21]  S. E. Barlow and W. H. Dietz, “Obesity evaluation and treatment: expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services,” Pediatrics, vol. 102, no. 3, p. E29, 1998.
[22]  T. Reinehr, M. Kersting, U. Alexy, and W. Andler, “Long-term follow-up of overweight children: after training, after a single consultation session, and without treatment,” Journal of Pediatric Gastroenterology and Nutrition, vol. 37, no. 1, pp. 72–74, 2003.
[23]  U. Korsten-Reck, S. Bauer, and J. Keul, “Sports and nutrition—an out-patient program for adipose children (long-term experience),” International Journal of Sports Medicine, vol. 15, no. 5, pp. 242–248, 1994.
[24]  J. Anavian, D. J. Brenner, P. Fort, and P. W. Speiser, “Profiles of obese children presenting for metabolic evaluation,” Journal of Pediatric Endocrinology and Metabolism, vol. 14, no. 8, pp. 1145–1150, 2001.
[25]  S. Ten and N. Maclaren, “Insulin resistance syndrome in children,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2526–2539, 2004.
[26]  S. D. Long, K. O'Brien, K. G. MacDonald et al., “Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes: a longitudinal interventional study,” Diabetes Care, vol. 17, no. 5, pp. 372–375, 1994.
[27]  E. Selvin, S. Marinopoulos, G. Berkenblit et al., “Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus,” Annals of Internal Medicine, vol. 141, no. 6, pp. 421–431, 2004.
[28]  A. Hamann and S. Matthaei, “Regulation of energy balance by leptin,” Experimental and Clinical Endocrinology and Diabetes, vol. 104, no. 4, pp. 293–300, 1996.
[29]  S. Caprio, W. V. Tamborlane, D. Silver et al., “Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations,” American Journal of Physiology, vol. 271, no. 3, pp. E626–E630, 1996.
[30]  S. Arslanian, C. Suprasongsin, S. C. Kalhan, A. L. Drash, R. Brna, and J. E. Janosky, “Plasma leptin in children: relationship to puberty, gender, body composition, insulin sensitivity, and energy expenditure,” Metabolism, vol. 47, no. 3, pp. 309–312, 1998.
[31]  A. Misra, “Risk factors for atherosclerosis in young individuals,” Journal of Cardiovascular Risk, vol. 7, no. 3, pp. 215–229, 2000.
[32]  K. V. K. Porkka and O. T. Raitakari, “Serum lipoproteins in children and young adults: determinants and treatment strategies,” Current Opinion in Lipidology, vol. 7, no. 4, pp. 183–187, 1996.
[33]  C. E. O'Neil, T. A. Nicklas, L. Myers, C. C. Johnson, and G. S. Berenson, “Cardiovascular risk factors and behavior lifestyles of young women: implications from findings of the bogalusa heart study,” American Journal of the Medical Sciences, vol. 314, no. 6, pp. 385–395, 1997.
[34]  S. R?ssner and H. Bjorvell, “Early and late effects of weight loss on lipoprotein metabolism in severe obesity,” Atherosclerosis, vol. 64, no. 2-3, pp. 125–130, 1987.
[35]  A. S. Poobalan, L. S. Aucott, E. Precious, I. K. Crombie, and W. C. S. Smith, “Weight loss interventions in young people (18 to 25 year olds): a systematic review,” Obesity Reviews, vol. 11, no. 8, pp. 580–592, 2010.


comments powered by Disqus